Diabetes affects millions of people worldwide, extending beyond physical health to impact daily life, mental well-being, family, and social relationships. According to the International Diabetes Federation, approximately 589 million adults aged 20-79 lived with diabetes in 2024, projected to rise to 853 million by 2050. In Algeria, 4.76 million adults were living with diabetes in 2024, with 1.51 million, or 31.7%, unaware of their condition.
Living with diabetes requires constant vigilance, including medication adherence, blood sugar monitoring, dietary adjustments, and regular exercise. Patients must also prepare for unexpected situations, such as eating out or traveling. The daily burden of diabetes can be overwhelming, with patients and families facing challenges in managing the condition, accessing care, and coping with emotional strain.
The psychological impact of diabetes should not be underestimated, as patients may experience anxiety, frustration, and feelings of guilt. Healthcare providers emphasize that quality of care should not only focus on blood sugar control but also on patients' mental health and ability to manage their condition. Support from family and friends is crucial, but it is essential to strike a balance between assistance and respecting patients' autonomy.
Prevention is key to reducing the diabetes burden, particularly for type 2 diabetes, which can be delayed or prevented through lifestyle interventions. A US study found that a program combining dietary improvements, physical activity, and weight loss of over 7% reduced the risk of developing type 2 diabetes by 58% over three years. The World Health Organization recommends at least 150 minutes of moderate-intensity physical activity per week and a balanced diet.
Early detection is also critical, as type 2 diabetes can remain asymptomatic for years. Screening programs, particularly in primary care settings, can help identify undiagnosed cases and enable timely interventions. In Algeria, strengthening early detection and follow-up care can help prevent complications and improve patient outcomes.
Advances in medical technology and treatment options have transformed diabetes care. Continuous glucose monitoring systems and innovative medications, such as SGLT2 inhibitors and GLP-1 receptor agonists, offer improved glucose control, cardiovascular benefits, and kidney protection. However, access to these technologies and treatments remains a challenge for many patients.
The Algerian government and healthcare providers must work together to address the growing diabetes burden. This includes promoting awareness, improving access to prevention and care services, and investing in innovative technologies and treatments. By prioritizing diabetes care and prevention, Algeria can reduce the impact of this chronic condition and improve the lives of millions of people affected.
Key points
- Algeria reports 4.76 million adults living with diabetes in 2024.
- 31.7% of Algerian diabetics are undiagnosed.
- Prevention and early detection are crucial to reducing the diabetes burden in Algeria.
